CAMBRIDGE, Mass., Aug. 9, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that management will deliver a corporate presentation at two upcoming healthcare conferences: Canaccord 30th Annual Global Growth Conference and the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference.
